Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials
09/2022
Journal Article
Authors:
Denicoff, Andrea M;
Ivy, S Percy;
Tamashiro, Tami T;
Zhao, Jinxiu;
Worthington, Katherine H;
Mooney, Margaret M;
Little, Richard F
Volume:
114
Pagination:
1437-1440
Issue:
11
Journal:
JNCI: Journal of the National Cancer Institute
URL:
https://academic.oup.com/jnci/article/114/11/1437/6680187
Keywords:
modernize eligibility
Cancer treatment trials
CTEP
Abstract:
In 2018, the Cancer Therapy Evaluation Program (CTEP) at the US National Cancer Institute published new protocol template language that focused on organ function and prior and concurrent cancers in an effort to modernize eligibility criteria for cancer treatment trials. We conducted an analysis of CTEP-supported trials to evaluate the uptake and incorporation of the new language. The analysis included evaluation of 122 protocols approved in the years 2018-2020 for inclusion of the modernized eligibility criteria and consistency with new protocol template language related to 7 major eligibility criteria. These were cardiac function, liver function, kidney function, HIV status, prior and/or concurrent malignancies, treated and/or stable brain metastasis, and new and/or progressive brain metastases. Overall, CTEP trials evaluated in this period demonstrated that eligibility criteria were implemented to a relatively high degree ranging from a low of 54.1% for prior and/or concurrent malignancies to a high of 93.4% for eligibility criteria related to HIV infection. The findings demonstrate that modernized eligibility criteria can be successfully implemented but that consistent implementation requires sustained focused effort. As a result of these findings, CTEP began a new initiative in January 2022 that incorporates a specific review of eligibility criteria for new protocols to promote and improve consistency with the modernization effort.
